Galapagos and Gilead Soldier On After Inflammatory Disease Flops
Clinical and regulatory setbacks have left the star biotech duo Gilead and Galapagos smarting and…
04/03/2021 - 4 minutes
Gilead
Galapagos’ Arthritis Drug Approved in EU and Japan Amid US Rejection
The recent EU and Japan approvals of the rheumatoid arthritis drug filgotinib contrast with the…
05/10/2020 - 5 minutes
Remdesivir Becomes the First Covid-19 Treatment Approved in Europe
Remdesivir has received a one-year conditional marketing authorization from the European Commission due to the…
08/07/2020 - 3 minutes
Gilead Pays Billions for Access to Galapagos’ Pipeline
Gilead has launched a 10-year collaboration with the Belgo-Dutch biotech Galapagos, paying at least €4.5B…
15/07/2019 - 2 minutes
Belgian and US Biotechs Team up to Reduce CAR T Side Effects
The diagnostics company Biocartis is collaborating with Kite Pharma to monitor the progress of CAR…
03/06/2019 - 3 minutes
Austrian Biopharma Reaches First HIV Vaccine Milestone
Hookipa Pharma has reached its first milestone in a partnership deal with US-based CAR T…
03/01/2019 - 2 minutes
Galapagos Reports Promising Phase III Data in Rheumatoid Arthritis
Galapagos and Gilead have reported positive results from a Phase III trial testing Galapagos’ lead…
12/09/2018 - 2 minutes
Novartis and Gilead’s CAR-T Therapies Now Compete for the Same Cancer Patients
The FDA has approved the use of Novartis' CAR-T therapy Kymriah in adult patients with…
02/05/2018 - 2 minutes
This Small German Biotech is Dealing with Big Pharma in NASH and Autoimmune Disease
This week we visit Ludwigshafen, a city in southwestern Germany across the river from Mannheim,…
14/07/2017 - 2 minutes
Galapagos and Gilead Launch the Fifth New Trial for Filgotinib this Year
With the addition of uveitis, Galapagos and Gilead are raising to 10 the number of…
05/07/2017 - 1 minute
BRIEF: Galapagos and Gilead add Lupus to their Growing List of Indications
Galapagos has announced a new Phase II study led by its partner Gilead to evaluate…
26/04/2017 - 1 minute
Dual HIV Therapy: GSK and Gilead Battle over Whose Drug is the Best
GSK announced Phase III results for dolutegravir, which could reduce triple HIV therapy down to…
14/02/2017 - 2 minutes
